Shyangs WebADCreg for Pharma Expand from RSS to Newsletter



To benefit users without an RSS reader, Shyang presents their newsletter service to complement the recently released web-ADC® for Pharma's8217;s RSS. Now newsletter users can receive the same pharmaceutical news contents as the RSS users through e-mail.

Web-ADC® for Pharma's8217;s RSS taps into 12 different news sites such as CNN, Reuters, Yahoo! and WebMD for pharmaceutical news. Then with statistical calculations of keywords, web-ADC® for Pharma's8217;s RSS prioritizes the collected data to give the top ten news of the day, and delivers them to the RSS users. Yet with Shyang's8217;s latest newsletter service, users without an RSS reader can receive the same content through e-mail as well.

According to a January 2006 survey done by the Consumer Federation of America, 's8220;get news's8221; is the third most important function Internet users rated out of 17 categories, just after e-mail and product research. web-ADC® for Pharma is Shyang's8217;s new product that provides automatic and personalized pharmaceutical news and patents. By combining e-mail and news delivery, Shyang wishes to accommodate more Internet users with a special interest in pharmaceutical news.

For subscription and real-time update of the content of web-ADC® for Pharma News, visit www.web-ADC.com.

About Shyang Information Corporation:

Shyang Information Corporation was founded in 1990 and provides automatic data collection (ADC) service. It latest product web-ADC® aims to globalize the collection of pharmaceutical information and is designed to deliver the latest pharmaceutical news and patent information. Recent new features include statistic analysis and topic map.





Shyangs WebADCreg for Pharma Expand from RSS to Newsletter